PCI Pharma Services, a global contract development and manufacturing organization (CDMO), has released its first Environmental, Social & Governance (ESG) Report—a detailed overview of its sustainability journey.
 
The report showcases the strides taken from the program’s formal inception in 2021 through its 2023 fiscal year and lays out ambitious goals for continued progress along multiple fronts.
 
The in-depth report discloses PCI’s performance, targets, and strategy to achieve nine identified impact categories, from sustainability-focused practices concerning carbon footprint, responsible waste management and eco-conscious procurement to people-first issues such as health and safety, community impact and DEI.
 
Highlights from PCI’s ESG report include:

Emission Reduction Targets

By 2030, PCI aims to reduce Scope 1 and 2 Greenhouse Gas emissions by 40%; cut its energy intensity by 50%; purchase 100% of its energy from renewable sources.
 
By 2045, PCI aims to achieve a Net-Zero carbon footprint across its entire supply chain.

Water Conservation

By 2030, PCI plans to reduce its global water consumption by 50% per cubic meter.

Waste Management

By 2030, PCI targets non-hazardous waste intensity reduction by 33%, reduction of waste sent to landfills by 90%, and has plans in place to reach 100% recycling of recyclable waste.